Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aptose Biosciences Inc. stock logo
APS
Aptose Biosciences
C$2.40
C$2.40
C$1.21
C$2.59
C$6.13M-1.2882653,887 shs2,945 shs
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
C$1.41
-5.4%
C$1.76
C$1.30
C$2.75
C$18.91M2.4148635,880 shs34,464 shs
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aptose Biosciences Inc. stock logo
APS
Aptose Biosciences
0.00%0.00%0.00%+9.09%+49.07%
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
-5.37%-7.84%-29.50%-37.05%-39.22%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aptose Biosciences Inc. stock logo
APS
Aptose Biosciences
C$2.40
C$2.40
C$1.21
C$2.59
C$6.13M-1.2882653,887 shs2,945 shs
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
C$1.41
-5.4%
C$1.76
C$1.30
C$2.75
C$18.91M2.4148635,880 shs34,464 shs
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aptose Biosciences Inc. stock logo
APS
Aptose Biosciences
0.00%0.00%0.00%+9.09%+49.07%
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
-5.37%-7.84%-29.50%-37.05%-39.22%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aptose Biosciences Inc. stock logo
APS
Aptose Biosciences
2.00
HoldN/AN/A
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aptose Biosciences Inc. stock logo
APS
Aptose Biosciences
N/AN/AC$1.50 per share1.60C($13.59) per shareN/A
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
C$3.20M5.60C$0.04 per share39.00C($0.71) per share-1.98
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aptose Biosciences Inc. stock logo
APS
Aptose Biosciences
-C$154.69M-C$10.41N/AN/AN/AN/A115.98%-136.29%N/A
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
-C$12.74M-C$1.16N/AN/AN/A-454.70%338.06%-39.22%N/A

Latest BU and APS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2026Q1 2027
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
N/A-C$0.30N/A-C$0.30N/AC$1.28 million
6/24/2026Q4 2026
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
N/A-C$0.29N/A-C$0.29N/AC$0.83 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Aptose Biosciences Inc. stock logo
APS
Aptose Biosciences
N/A0.39%N/AN/AN/A
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
N/A4.45%N/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aptose Biosciences Inc. stock logo
APS
Aptose Biosciences
-98.74
0.55
5.41
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
-319.77
0.21
1.71

Institutional Ownership

CompanyInstitutional Ownership
Aptose Biosciences Inc. stock logo
APS
Aptose Biosciences
0.02%
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
0.05%

Insider Ownership

CompanyInsider Ownership
Aptose Biosciences Inc. stock logo
APS
Aptose Biosciences
17.11%
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
28.06%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aptose Biosciences Inc. stock logo
APS
Aptose Biosciences
312.55 millionN/ANot Optionable
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
2012.69 millionN/ANot Optionable

Recent News About These Companies

Burcon Announces Fiscal 2026 Results
Defiance ETFs Announces Closure of BU and CVNX Funds
Burcon Announces Appointment of New Director
Burcon NutraScience

New MarketBeat Followers Over Time

Media Sentiment Over Time

Aptose Biosciences stock logo

Aptose Biosciences TSE:APS

C$2.40 0.00 (0.00%)
As of 07/3/2026

Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies. The company has an agreement with CrystalGenomics, Inc. to research, develop, and commercialize CG026806, a non-covalent small molecule therapeutic agent, which is in preclinical stage for the treatment of acute myeloid leukemia and chronic lymphocytic leukemia/mantle cell lymphoma. The company was formerly known as Lorus Therapeutics Inc. and changed its name to Aptose Biosciences Inc. in August 2014. Aptose Biosciences Inc. was founded in 1986 and is headquartered in Mississauga, Canada.

Burcon NutraScience stock logo

Burcon NutraScience TSE:BU

C$1.41 -0.08 (-5.37%)
As of 09/14/2026 03:59 PM Eastern

Burcon is a global technology leader in plant-based proteins for food and beverage applications. The Company has developed a portfolio of high-performance protein ingredients, including Peazzaz® pea proteins, FavaPro TM fava proteins and Puratein® canola proteins, and is focused on commercializing its technologies through manufacturing partnerships and growing customer adoption worldwide.